Regorafenib and Nivolumab in Mismatch Repair (MMR) Refractory Colorectal Cancer
Conditions: Colorectal Cancer; Metastatic Colorectal Cancer; Colon Cancer Interventions: Drug: Regorafenib; Drug: Nivolumab Sponsors: H. Lee Moffitt Cancer Center and Research Institute; Bristol-Myers Squibb Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials